Skip to main content

Month: April 2020

Noront Resources Announces Issuance of Interest Shares

TORONTO, April 13, 2020 (GLOBE NEWSWIRE) — Noront Resources Ltd. (“Noront”) (TSX Venture: NOT) announces that payment of interest in the amount of $424,182 for the first quarter of 2020 pursuant to a loan agreement entered into between Noront and Resource Capital Funds V L.P. (“RCF”) dated February 26, 2013 (the “Loan Agreement”) has been satisfied by delivery of 2,750,856 common shares of the Company (the “Interest Shares”) at an effective price of $0.1542 per Interest Share.  The Interest Shares were delivered on April 13, 2020 subject to a four month hold period, expiring on August 14, 2020.The calculation of the number of Interest Shares issued was based on the volume weighted average trading price of the common shares of the Company during the 20 trading days prior to March 31, 2020.After giving effect to the issuance...

Continue reading

Live Ventures Announces First Quarter Fiscal 2020 Financial Results

LAS VEGAS, April 13, 2020 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, announced financial results for its first quarter of fiscal year 2020, which ended December 31, 2019.  The company reported quarterly revenue of $42.0 million and basic EPS (earnings per share) of $0.30.  The company also reported an increase in operating income of 67% year-over-year of $3.5 million and repurchased 41,699 shares of its common stock during the first fiscal quarter.The company reported total assets and liabilities of $136.2 million and $101.6 million, respectively, as of December 31, 2019. The increase in total assets and liabilities of approximately $13.7 million and $13.2 million, respectively, since the beginning of the company’s current fiscal year is primarily related to the adoption of the new...

Continue reading

Ferrellgas, L.P. Announces Pricing of $125 Million of its 10.000% Senior Secured First Lien Notes Due 2025

OVERLAND PARK, Kan., April 13, 2020 (GLOBE NEWSWIRE) — Ferrellgas, L.P. (the “Company”) and its wholly-owned subsidiary Ferrellgas Finance Corp. (together, the “Issuers”) announced the pricing of their previously announced add-on offering (the “Add-on Offering”) of $125 million aggregate principal amount of 10.000% Senior Secured First Lien Notes due 2025 (the “Additional Notes”) at an offering price equal to 103% of the principal thereof. The Issuers offered and priced $575 million aggregate principal amount of their 10.000% senior secured first lien notes due 2025 (the “Initial Notes”) on April 8, 2020. The Additional Notes will be governed by the same indenture, and will have the same terms, as the Initial Notes. The Additional Notes will be senior secured first lien obligations of the Issuers and will be guaranteed on a senior...

Continue reading

LogistiCare l Circulation innovating services to meet the changing needs amid COVID-19 pandemic

Atlanta, April 13, 2020 (GLOBE NEWSWIRE) — COVID-19 has brought grief and hardship to many and instilled uncertainty to all.  At LogistiCare l Circulation, we are focused on supporting our communities, patients and healthcare providers during these extraordinary times. LogistiCare l Circulation is innovating our services at record speed.  At its core, our company connects people, facilitating more than 63 million rides each year for our clients’ members and patients to and from their healthcare-related appointments.  During this period of social distancing, LogistiCare continues to enhance our Interactive Voice Response (“IVR”) system to allow identification of COVID-19 symptomatic members in order to route to the safest mode of transport.  In alignment with State Medicaid guidance and the CDC, it is our mission to provide access...

Continue reading

GCC ANNOUNCES Q1 2020 CONFERENCE CALL DETAILS

CHIHUAHUA, Mexico, April 13, 2020 (GLOBE NEWSWIRE) — Grupo Cementos de Chihuahua, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a conference call to review its first quarter 2020 earnings results on Wednesday, April 29 at 11:00 a.m. (ET). Earnings results for the quarter ended March 31, 2020, will be released on Tuesday, April 28 after market close.

Continue reading

CORRECTION: VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT

Not for distribution by US newswire or in United StatesNESS-ZIONA, Israel, April 13, 2020 (GLOBE NEWSWIRE) — A correction has been issued for the release disseminated at 8:30 AM, April 13th. Some outlets mistakenly replaced the header with the subheader. The complete and corrected release follows.VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, is pleased to share the results of our first preclinical experiment whose purpose was to test the immune response of our COVID-19 vaccine candidate. These results provide the first pre-clinical validation of our in silico modelling announced a few weeks ago.By leveraging its platform, Vaxil discovered a potential peptide vaccine against COVID-19 back in February 2020 and then proceeded...

Continue reading

Manhattan Bridge Capital, Inc. Reports First Quarter 2020 Results

GREAT NECK, N.Y., April 13, 2020 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that net income for the three months ended March 31, 2020 was approximately $1,016,000, or $0.11 per basic and diluted share (based on approximately 9.7 million weighted-average outstanding common shares), versus approximately $1,121,000, or $0.12 per basic and diluted share (based on approximately 9.7 million weighted-average outstanding common shares) for the three months ended March 31, 2019, a decrease of $105,000, or 9.4%. This decrease is primarily attributable to the decrease in revenue and the increase in general and administrative expenses, offset by the decrease in interest expense due to lower LIBOR rates.Total revenues for the three months ended March 31, 2020 were approximately $1,711,000 compared to approximately...

Continue reading

Teck Announces Change in Location of Annual Meeting of Shareholders

VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) announced today that in light of the ongoing global COVID-19 pandemic and the temporary closure of the original venue described in the Notice of Meeting dated February 28, 2020 previously sent to shareholders, the annual meeting of shareholders scheduled for Tuesday, April 21, 2020 will now be held at Teck’s head office in Vancouver located at Suite 3300 – 550 Burrard Street.  As previously advised, in order to mitigate potential risks to the health and safety of its shareholders, employees, communities, and service providers for the annual meeting, Teck is urging shareholders and others not to attend the annual meeting in person. Instead, shareholders should vote on the matters before the meeting by...

Continue reading

Karolinska Development makes a partial sale of its holdings in the portfolio company Aprea Therapeutics and receives a net of SEK 59 million

STOCKHOLM, SWEDEN – April 13, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that it has divested part of its holding in the portfolio company Aprea Therapeutics, Inc. (“Aprea”). KCIF Co-investment Fund KB – a holding company jointly owned by the European Investment Fund and Karolinska Development – has also sold shares in Aprea in the same transaction. In total, the transaction comprises 1 percent of the total outstanding shares in Aprea and brings net approx. SEK 59 million to Karolinska Development. Karolinska Development’s remaining holding in Aprea, including indirect holding through KCIF Co-investment Fund, amounts to approximately 1 percent of the total outstanding shares in Aprea.  KDev Investment’s holding remains unchanged at approximately 9.5 percent of the total number of outstanding...

Continue reading

Karolinska Development säljer delar av innehavet i portföljbolaget Aprea Therapeutics och erhåller netto 59 miljoner SEK

STOCKHOLM, SVERIGE 13 april 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att man avyttrat en del av sitt innehav i portföljbolaget Aprea Therapeutics. KCIF Co-investment Fund KB – ett holdingbolag gemensamt ägt av Europeiska Investeringsfonden och Karolinska Development – har också avyttrat aktier i Aprea i samma transaktion. Totalt omfattar transaktionen 1 procent av samtliga utestående aktier i Aprea och inbringar netto cirka 59 mkr till Karolinska Development. Karolinska Developments kvarvarande innehav i Aprea, inklusive indirekt innehav genom KCIF Co-investment Fund, uppgår till cirka 1 procent av det totala antalet utestående aktier. KDev Investments innehav i Aprea är oförändrat och uppgår till cirka 9,5 procent av det totala antalet utestående aktier.”Apreas framgångsrika börsintroduktion i USA i slutet...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.